この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2012/6/141 分で読めます
Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled "Irritable Bowel Syndrome--Clinical Evaluation of Drugs for Treatment." The document was published with an incorrect docket number. This document corrects that error.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →